3995 results
Keyword EPAR Remove keyword
-
List item
Press release: EPAR summaries for the public: A further step for the provision of better information about medicines
Last updated: 02/02/2009EPAR summaries for the public … EMEA/40317/2006 PRESS RELEASE EPAR summaries for the public … public assessment reports (EPARs) that are specially written … -
List item
Press release: European Medicines Agency and EUnetHTA Joint Action start collaboration on European Public Assessment Report (EPAR) contribution to relative effectiveness assessments
Last updated: 16/02/2010Public Assessment Report (EPAR) contribution to relative … Public Assessment Report (EPAR) could make a better contribution … collaboration will be the EPARs, which are published by the … -
List item
Veterinary medicine European public assessment report (EPAR): Mirataz (updated)
mirtazapine, Cats
Date of authorisation: 10/12/2019, Revision: 1, Authorised, Last updated: 10/07/2020 -
List item
Human medicine European public assessment report (EPAR): Cymbalta (updated)
duloxetine, Anxiety Disorders, Diabetic Neuropathies, Depressive Disorder, Major
Date of authorisation: 17/12/2004, Revision: 29, Authorised, Last updated: 06/08/2020Cymbalta duloxetine EPAR summary for the public … Public Assessment Report (EPAR). It explains how the Committee … Leaflet (also part of the EPAR) or contact your doctor or … -
List item
Human medicine European public assessment report (EPAR): Picato (updated)
Ingenol mebutate, Keratosis, Actinic
Date of authorisation: 15/11/2012,
, 
, Revision: 10, Withdrawn, Last updated: 31/07/2020
Picato : EPAR - Summary for the public … -
List item
Human medicine European public assessment report (EPAR): Yentreve (updated)
duloxetine hydrochloride, Urinary Incontinence, Stress
Date of authorisation: 11/08/2004, Revision: 26, Authorised, Last updated: 24/07/2020PUBLIC ASSESSMENT REPORT (EPAR) YENTREVE EPAR summary for the public … Public Assessment Report (EPAR). It explains how the Committee … Leaflet (also part of the EPAR) or contact your doctor or … -
List item
Human medicine European public assessment report (EPAR): Nimenrix (updated)
Neisseria meningitidis serogroup A polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis serogroup C polysaccharide conjugated to tetanus toxoid / Neisseria meningitidis serogroup W-135 polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis serogroup Y polysaccharide conjugated to tetanus toxoid, Meningitis, Meningococcal
Date of authorisation: 20/04/2012, Revision: 30, Authorised, Last updated: 31/07/2020public assessment report (EPAR), and will be available … Nimenrix : EPAR - Medicine oveview (PDF/127.71 … -
List item
Human medicine European public assessment report (EPAR): Enbrel (updated)
etanercept, Spondylitis, Ankylosing, Arthritis, Juvenile Rheumatoid, Arthritis, Psoriatic, Psoriasis, Arthritis, Rheumatoid
Date of authorisation: 02/02/2000, Revision: 61, Authorised, Last updated: 28/07/2020EMA/398383/2014 EMEA/H/C/000262 EPAR summary for the public Enbrel … public assessment report (EPAR) for Enbrel. It explains … characteristics (also part of the EPAR). The medicine can only be … -
List item
Human medicine European public assessment report (EPAR): Humira
adalimumab, Spondylitis, Ankylosing, Arthritis, Juvenile Rheumatoid, Uveitis, Colitis, Ulcerative, Psoriasis, Arthritis, Psoriatic, Crohn Disease, Arthritis, Rheumatoid
Date of authorisation: 08/09/2003, Revision: 76, Authorised, Last updated: 04/05/2020 -
List item
Human medicine European public assessment report (EPAR): Celsentri (updated)
maraviroc, HIV Infections
Date of authorisation: 18/09/2007, Revision: 25, Authorised, Last updated: 28/07/2020EMA/288232/2017 EMEA/H/C/000811 EPAR summary for the public Celsentri … public assessment report (EPAR) for Celsentri. It explains … September 2007. The full EPAR for Celsentri can be found … -
List item
Human medicine European public assessment report (EPAR): Taltz
ixekizumab, Psoriasis
Date of authorisation: 25/04/2016,, Revision: 10, Authorised, Last updated: 07/07/2020
EMA/171915/2016 EMEA/H/C/003943 EPAR summary for the public Taltz … public assessment report (EPAR) for Taltz. It explains how … characteristics (also part of the EPAR). Taltz EMA/171915/2016 … -
List item
Human medicine European public assessment report (EPAR): Lyrica
pregabalin, Epilepsy, Anxiety Disorders, Neuralgia
Date of authorisation: 05/07/2004, Revision: 45, Authorised, Last updated: 12/06/2020EMA/229012/2010 EMEA/H/C/546 EPAR summary for the public Lyrica … Public Assessment Report (EPAR) for Lyrica. It explains … unlimited period. The full EPAR for Lyrica can be found here … -
List item
Human medicine European public assessment report (EPAR): Prezista
darunavir, HIV Infections
Date of authorisation: 11/02/2007, Revision: 48, Authorised, Last updated: 17/06/2020EMA/692664/2014 EMEA/H/C/000707 EPAR summary for the public Prezista … public assessment report (EPAR) for Prezista. It explains … February 2007. The full EPAR for Prezista can be found … -
List item
Human medicine European public assessment report (EPAR): Voncento (updated)
Human coagulation factor VIII, human von willebrand factor, Hemophilia A, von Willebrand Diseases
Date of authorisation: 12/08/2013, Revision: 14, Authorised, Last updated: 21/07/2020EMA/654233/2017 EMEA/H/C/02493 EPAR summary for the public Voncento … public assessment report (EPAR) for Voncento. It explains … August 2013. The full EPAR for Voncento can be found … -
List item
Human medicine European public assessment report (EPAR): Temozolomide Teva (updated)
temozolomide, Glioma, Glioblastoma
Date of authorisation: 28/01/2010,
, Revision: 19, Authorised, Last updated: 10/07/2020
EMA/523990/2014 EMEA/H/C/001126 EPAR summary for the public Temozolomide … public assessment report (EPAR) for Temozolomide Teva. It … information. Abbreviated as EPAR. More information can be found … -
List item
Human medicine European public assessment report (EPAR): Puregon (updated)
follitropin beta, Infertility, Hypogonadism
Date of authorisation: 02/05/1996, Revision: 28, Authorised, Last updated: 27/07/2020PUBLIC ASSESSMENT REPORT (EPAR) PUREGON EPAR summary for the public … Public Assessment Report (EPAR). It explains how the Committee … Leaflet (also part of the EPAR) or contact your doctor or … -
List item
Human medicine European public assessment report (EPAR): Firmagon (updated)
degarelix, Prostatic Neoplasms
Date of authorisation: 17/02/2009, Revision: 15, Authorised, Last updated: 24/07/2020PUBLIC ASSESSMENT REPORT (EPAR) FIRMAGON EPAR summary for the public … Public Assessment Report (EPAR). It explains how the Committee … Leaflet (also part of the EPAR) or contact your doctor or … -
List item
Human medicine European public assessment report (EPAR): Temozolomide Hexal (updated)
temozolomide, Glioma, Glioblastoma
Date of authorisation: 15/03/2010,, Revision: 16, Authorised, Last updated: 22/07/2020
EMA/729961/2014 EMEA/H/C/001127 EPAR summary for the public Temozolomide … Public Assessment Report (EPAR) for Temozolomide Hexal … Public Assessment Report (EPAR) for Temozolomide Hexal … -
List item
Human medicine European public assessment report (EPAR): Emtriva (updated)
emtricitabine, HIV Infections
Date of authorisation: 24/10/2003, Revision: 30, Authorised, Last updated: 23/07/2020EMA/721606/2016 EMEA/H/C/000533 EPAR summary for the public Emtriva … public assessment report (EPAR) for Emtriva. It explains … October 2003. The full EPAR for Emtriva can be found … -
List item
Human medicine European public assessment report (EPAR): Entresto (updated)
sacubitril, valsartan, Heart Failure
Date of authorisation: 19/11/2015, Revision: 10, Authorised, Last updated: 22/07/2020EMA/782147/2015 EMEA/H/C/004062 EPAR summary for the public Entresto … public assessment report (EPAR) for Entresto. It explains … characteristic (also part of the EPAR). How does Entresto work … -
List item
Human medicine European public assessment report (EPAR): Otezla (updated)
apremilast, Arthritis, Psoriatic, Psoriasis
Date of authorisation: 15/01/2015, Revision: 14, Authorised, Last updated: 21/07/2020EMA/727043/2014 EMEA/H/C/003746 EPAR summary for the public Otezla … public assessment report (EPAR) for Otezla. It explains … January 2015. The full EPAR and risk management plan … -
List item
Human medicine European public assessment report (EPAR): Ecalta (updated)
anidulafungin, Candidiasis
Date of authorisation: 20/09/2007, Revision: 22, Authorised, Last updated: 31/07/2020public assessment reports (EPARs) for each medicine: ema.europa.eu/Find … characteristics (also part of the EPAR). What benefits of Ecalta have … -
List item
Human medicine European public assessment report (EPAR): Ivemend
fosaprepitant, Vomiting, Cancer
Date of authorisation: 11/01/2008, Revision: 22, Authorised, Last updated: 16/06/2020Summary documents Ivemend : EPAR - Medicine overview PDF icon … product characteristics This EPAR was last updated on 16/06/2020 … EMEA/H/C/000743 - IB/0042 Ivemend : EPAR - Product Information PDF … -
List item
Human medicine European public assessment report (EPAR): Zoely
Nomegestrol acetate, estradiol, Contraception
Date of authorisation: 26/07/2011,, Revision: 19, Authorised, Last updated: 03/07/2020
EMA/216210/2016 EMEA/H/C/001213 EPAR summary for the public Zoely … public assessment report (EPAR) for Zoely. It explains how … 27 July 2011. The full EPAR for Zoely can be found on … -
List item
Human medicine European public assessment report (EPAR): Avastin
bevacizumab, Carcinoma, Non-Small-Cell Lung, Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Carcinoma, Renal Cell
Date of authorisation: 12/01/2005, Revision: 55, Authorised, Last updated: 24/06/2020information. Abbreviated as EPAR. More information can be found … public assessment report (EPAR) for Avastin. It explains …